Scientific innovation is transforming healthcare. Breakthroughs in advanced therapies, precision medicine, digital health, data, and AI are opening new possibilities for patients, healthcare systems, and life sciences organisations. At the same time, R&D leaders are operating in an increasingly complex environment, shaped by rising development costs, evolving regulation, competitive pressure, operational complexity, and the need to demonstrate value earlier and more consistently.
In this context, successful R&D requires more than scientific excellence. It calls for sharper portfolio choices, stronger evidence generation, smarter use of data and technology, more agile operating models, and deeper collaboration across the healthcare ecosystem.
PwC helps life sciences organisations navigate this full innovation journey — from R&D strategy and portfolio decisions to clinical development, technology transfer, evidence generation, operational transformation, and commercial readiness.
We combine deep healthcare and life sciences expertise with capabilities in strategy, technology, data, operations, and transformation. Our focus is to help organisations accelerate innovation, improve decision-making, and translate scientific progress into meaningful impact for patients.
R&D organisations face difficult choices about where to invest, how to prioritise assets, and how to allocate resources across increasingly complex pipelines. The ability to make these decisions with confidence is essential to improving productivity and long-term value creation.
PwC helps organisations define R&D strategies that are aligned with scientific ambition, market opportunity, patient need, and organisational capability. We support portfolio optimisation, asset prioritisation, governance design, performance management, and investment decision-making.
Our approach combines strategic insight, evidence-based analysis, and practical implementation support to help pharmaceutical, biotech, and medtech organisations focus their R&D efforts where they can create the greatest impact.
Clinical development is undergoing significant change. New trial designs, decentralised and hybrid models, digital tools, real-world evidence, and increasing patient involvement are reshaping how clinical research is planned and delivered.
PwC supports organisations in modernising clinical development models to improve efficiency, quality, patient centricity, and speed. We help clients assess current capabilities, redesign operating models, strengthen governance, adopt digital and data-driven approaches, and implement innovative trial solutions.
Our work helps organisations reduce complexity, improve collaboration, and bring new treatments to patients more effectively.
The lab is a vital part of the path from molecule to patient value. Clinical development and advanced therapies rely on accurate, timely, and well-managed lab data. But many labs still use isolated systems, manual tasks and scattered data. This can slow research, cause duplication, and make it tough for scientists and technical experts to quickly produce reliable insights.
PwC helps organisations define and deliver their Lab of the Future ambition. We accompany clients from strategy through to implementation, evaluating current lab maturity, rethinking workflows, building practical roadmaps, and setting up more connected, automated, and data-driven analytical environments.
By merging lab operations, digital technology, and data, we help organisations connect instruments and systems, capture data more effectively, and reduce manual work. The outcome is a SMART lab environment that improves efficiency, enhances reproducibility, and gives scientists and experts more time to focus on higher-value scientific tasks.
Data and AI are becoming central to the future of R&D. From identifying research opportunities and improving study design to generating real-world evidence and supporting decision-making, advanced analytics can unlock significant value across the innovation lifecycle.
PwC helps organisations harness data and AI responsibly and effectively. We support the development of evidence generation strategies, real-world evidence capabilities, data-driven decision models, and AI-enabled R&D solutions.
We also help organisations establish the governance, operating models, and controls needed to use data and AI in a trusted, compliant, and scalable way.
Advanced therapies and precision medicine are changing the way diseases are understood, treated, and managed. These innovations create major opportunities, but they also bring new challenges related to development strategy, manufacturing readiness, technology transfer, regulatory requirements, supply chain complexity, and patient access.
PwC works with organisations developing and delivering advanced therapies to help them navigate this complexity. We support CMC strategy development, operating model design, technology transfer, manufacturing readiness, ecosystem collaboration, and scale-up.
By connecting scientific ambition with operational and commercial realities, we help organisations move innovation closer to patients.
Healthcare innovation increasingly depends on collaboration. No single organisation can address the complexity of modern R&D alone. Partnerships between pharmaceutical companies, biotech firms, medtech players, research institutions, hospitals, technology companies, regulators, payers, and patient organisations are becoming essential.
PwC helps organisations identify, structure, and manage strategic partnerships across the health innovation ecosystem. We support ecosystem mapping, collaboration models, partnership strategies, and governance frameworks that help organisations accelerate innovation and create shared value.
Through stronger ecosystem collaboration, organisations can access new capabilities, reduce development risks, and increase the likelihood that innovation reaches patients successfully.
In a fast-moving innovation environment, timely and reliable market intelligence is critical. Organisations need to understand scientific trends, competitor activity, patient needs, regulatory dynamics, market access pathways, and evolving stakeholder expectations.
PwC helps organisations build the capabilities required to generate, interpret, and act on strategic insights. We support competitive landscape assessments, market opportunity analysis, stakeholder mapping, and evidence-based decision-making across the R&D lifecycle.
By turning fragmented information into clear strategic insight, we help organisations make better choices, anticipate change, and strengthen their position in the market.
The future of R&D will be more connected, data-driven, and patient-focused. Organisations will need to make better portfolio choices, adopt new technologies responsibly, collaborate more effectively, and build operating models that can respond to scientific and market change.
PwC helps life sciences organisations move from ambition to execution. Whether the priority is strengthening R&D strategy, transforming clinical development, improving evidence generation, scaling advanced therapies, or building ecosystem partnerships, we bring the expertise and practical support needed to deliver meaningful progress.
Together, we can help accelerate innovation and turn scientific breakthroughs into better outcomes for patients.
Connect with PwC to explore how we can help your organisation strengthen its R&D strategy, transform development models, and bring innovation closer to patients.
